MedTrace Logo

The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

NCT05672407 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2023-09-21

No results posted yet for this study

Summary

This study investigates the effect of tranexamic acid, a medication that helps reduce bleeding, in patients undergoing surgeries around their eyes.

Conditions

  • Eyelid Diseases
  • Periorbital Disorder
  • Hemorrhage
  • Surgical Blood Loss

Interventions

DRUG

Tranexamic acid

100 mg/mL Tranexamic acid with lidocaine with 1:100,000 epinephrine in 1:1 manner administered subcutaneously

DRUG

Placebo

Lidocaine with 1:100,000 epinephrine mixed with 1:1 Basal Saline Solution (BSS) administered subcutaneously

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Wendy W Lee, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2026-06-01
Completion
2026-06-01
FDA Drug
Yes

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05672407 on ClinicalTrials.gov